Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Your view on WBA
Overview
What the company does, where it operates, and who runs it.
About Walgreens Boots Alliance, Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Timothy C. Wentworth
- Headquarters
- US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Timothy C. Wentworth
- Headquarters
- US
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International.
The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services.
As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies.
The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application.
It also engages in pharmaceutical wholesaling and distribution business in Germany.
As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis.
Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Walgreens Boots Alliance, Inc. from FRC's valuation model, read against the market price. WBA last traded at $11.98; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Walgreens Boots Alliance, Inc.. Starting points for Walgreens Boots Alliance, Inc.: EPS -$10.01, beta 0.77 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Walgreens Boots Alliance, Inc.. Walgreens Boots Alliance, Inc. paid $1.00 per share over the last year — a 8.3% yield at the current $11.98 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Walgreens Boots Alliance, Inc.. Trailing twelve-month EPS for Walgreens Boots Alliance, Inc. stands at -$10.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$23.57
average of analysts' targets
Analyst Ratings
- Strong Buy0
- Buy5
- Hold17
- Sell9
- Strong Sell0
Earnings Estimate
| EPS | Current QtrAug 2025 | Next QtrNov 2025 | Current YearFY Aug 2025 | Next YearFY Aug 2026 |
|---|---|---|---|---|
| Avg. estimate | $0.24 | $0.43 | $1.77 | $1.57 |
| Low estimate | $0.19 | $0.43 | $1.68 | $1.13 |
| High estimate | $0.30 | $0.43 | $1.86 | $1.73 |
| No. of analysts | 4 | 1 | 6 | 5 |
| Year-ago EPS | $0.39 | $0.51 | -$10.01 | — |
| Growth | -39.1% | -16.2% | +117.7% | — |
Revenue Estimate
| Revenue | Current QtrAug 2025 | Next QtrNov 2025 | Current YearFY Aug 2025 | Next YearFY Aug 2026 |
|---|---|---|---|---|
| Avg. estimate | $37.41B | $39.26B | $154.47B | $155.99B |
| Low estimate | $35.98B | $36.88B | $151.79B | $146.86B |
| High estimate | $38.81B | $41.63B | $157.94B | $162.14B |
| No. of analysts | 4 | 2 | 7 | 7 |
| Year-ago revenue | $37.55B | $39.46B | $147.66B | — |
| Growth | -0.4% | -0.5% | +4.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Walgreens Boots Alliance, Inc.. Walgreens Boots Alliance, Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ABBVAbbVie Inc.Drug Manufacturers - General$520.9B
- BIMIBIMI International Medical Inc.Medical - Distribution$1,156
- CVSCVS Health CorporationMedical - Healthcare Plans$113.3B
- HITIHigh Tide Inc.Medical - Pharmaceuticals$211M
- KHCThe Kraft Heinz CompanyPackaged Foods$29.7B
- MMM3M CompanyConglomerates$93.9B
- PETSPetMed Express, Inc.Specialty Retail$20M
- RDGTRidgetech Inc.Medical - Distribution$4M
More Medical - Pharmaceuticals companies
- TRGMTargeted Medical Pharma, Inc.OTC$3,019
- TSUSFTsuruha Holdings Inc.OTC$4.2B
- UPPRUpper Street Marketing Inc.OTC$7,995
- VIAPVIA Pharmaceuticals, Inc.OTC$10,279
- WPHMWinston Pharmaceuticals, Inc.OTC$23,223
- WUHNWuhan General Group (China), Inc.OTC$22,060
- NEUNNeurogenesis, Inc.OTC$8,226
- NEXINexImmune, Inc.OTC$279
- NSRXNasus Pharma Ltd.AMEX$23M
- NUNZNunzia Pharmaceutical CompanyOTC$43,451
- OMHEOmni Health, Inc.OTC$29,291
- ORXOFOrexo AB (publ)OTC$111M
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Walgreens Boots Alliance, Inc., and how their positions are changing. At a $10.37B market value, institutional positions materially move Walgreens Boots Alliance, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Walgreens Boots Alliance, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Walgreens Boots Alliance, Inc.. Walgreens Boots Alliance, Inc. is a $10.37B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Walgreens Boots Alliance, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Walgreens Boots Alliance, Inc.. Coverage tracks Walgreens Boots Alliance, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Walgreens Boots Alliance, Inc.